Dr. Singh's research interests in cancer immunobiology, health disparity, drug discovery, precision oncology, nanotechnology, and chemokines, using in silico, in vitro, and in vivo models, contribute to multiple disciplines, including basic and translational oncology, vaccine development, and chemoprevention.



His long-term goal is to improve cancer patients' therapeutic outcomes and overall survival and train the underrepresented groups, thereby enhancing the diversity of the future biomedical workforce.